Stock Research: LeMaitre Vascular

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

LeMaitre Vascular

NasdaqGM:LMAT US5255582018
100
  • Value
    93
  • Growth
    73
  • Safety
    Safety
    42
  • Combined
    96
  • Sentiment
    86
  • 360° View
    360° View
    100
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

LeMaitre Vascular, Inc. provides devices, implants, and services for treating peripheral vascular disease. The company operates in the medical devices industry, focusing on vascular surgery and related specialties. Its main markets include the United States, Europe, Canada, and Asia Pacific. In the last fiscal year, the company had a market cap of $1,872 million, profits of $151 million, revenue of $220 million, and 651 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 100 (better than 100% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock LeMaitre Vascular are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for LeMaitre Vascular. The consolidated Growth Rank has a good rank of 73, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 73% of competitors in the same industry. The consolidated Safety Rank at 93 means that the company has a financing structure that is safer than 93% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 86, which means that professional investors are more optimistic about the stock than for 86% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 42, meaning that the share price of LeMaitre Vascular is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 58% of alternative stocks in the same industry. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
42 37 51 83
Growth
73 93 65 85
Safety
Safety
93 20 92 84
Sentiment
86 79 92 64
360° View
360° View
100 98 63 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
42 61 53 48
Opinions Change
50 50 50 50
Pro Holdings
n/a 65 75 28
Market Pulse
91 81 95 93
Sentiment
86 79 92 64
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
42 37 51 83
Growth
73 93 65 85
Safety Safety
93 20 92 84
Combined
96 61 89 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
23 10 20 48
Price vs. Earnings (P/E)
11 7 19 45
Price vs. Book (P/B)
29 27 41 44
Dividend Yield
86 92 94 96
Value
42 37 51 83
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
50 61 50 33
Profit Growth
77 89 94 71
Capital Growth
57 37 25 82
Stock Returns
55 95 73 73
Growth
73 93 65 85
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
46 100 100 57
Refinancing
53 26 31 37
Liquidity
95 1 82 85
Safety Safety
93 20 92 84

Similar Stocks

Discover high‑ranked alternatives to LeMaitre Vascular and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.